Sep. 17, 2024
Professor Jeffrey Cummings’ highly regarded 2024 annual report on the state of clinical trials was featured in a journal of the Alzheimer’s Association. Cummings is co-director for two Alzheimer’s observatories — one for drug development and another for biomarkers — within UNLV’s Department of Brain Health. These are the only observatories of their kind in the world and they collect and disseminate data that keeps policy makers, healthcare systems, and patients in the know and offers hope in the continued push toward a cure.